Liquid Biopsies: Emerging role and clinical applications in solid tumours

• DOI: 10.1016/j.tranon.2023.101716
• Publication Date: 2023-06-16T01:04:06Z
• Authors: Sandeep Sisodiya; Vishakha Kasherwal; Asiya Khan; Bishnudeo Roy; Anjana Goel; Sandeep Kumar; Nazneen Arif; Pranay Tanwar; Showket Hussain
• Keywords: cell-free DNA; circulating tumour cells; circulating tumour DNA; Commentary; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; solid tumours; RC254-282; 3. Good health; Liquid biopsies

Late detection and lack of precision diagnostics are the major challenges in cancer prevention and management. Biomarker discovery in specific cancers, especially at the pre-invasive stage, is vital for early diagnosis, positive treatment response, and good disease prognosis. Traditional diagnostic measures require invasive procedures such as tissue excision using a needle, an endoscope, and/or surgical resection which can be unsafe, expensive, and painful. Additionally, the presence of comorbid conditions in individuals might render them ineligible for undertaking a tissue biopsy, and in some cases, it is difficult to access tumours depending on the site of occurrence. In this context, liquid biopsies are being explored for their clinical significance in solid malignancies management. These non-invasive or minimally invasive methods are being developed primarily for identification of biomarkers for early diagnosis and targeted therapeutics. In this review, we have summarised the use and importance of liquid biopsy as significant tool in diagnosis, prognosis prediction, and therapeutic development. We have also discussed the challenges that are encountered and future perspective.